Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Brasco One who wrote (3088)	10/26/2010 8:40:13 PM
From: tnsaf	1 Recommendation Respond to of 3722

Yes, it is going to be delisted! Probably desperate people trying to draw in the momentum traders so they can get out.

To: Brasco One who wrote (3088)	10/28/2010 9:00:12 AM
From: Jibacoa	Read Replies (3) \| Respond to of 3722

NURO has been forming a base at the $0.52 level.<g> It raised $18.7M last month in a private placement Trading around 0.4x BV But is always better to buy stocks on the way up, or when they are on an UT.<g> I am not in favor of bottom fishing. More inclined to Bill O'Neal strategy of buying high to sell higher, rather than buying low to sell high. Provided that one keeps adequate trailing stops and is willing to take a loss if the entry point turns out to be wrong.<g> The EL for NURO for 2010 is around $0.75 vs. $0.40 in 2009 Revenues have been lower for the last 4Qs and it has not been able to trim its losses. The ACTAY is $3.50 My TT is $1, which would be a good % gain from present levels. But I would prefer to buy it on the way up.<g> stockcharts.com Bernard